Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers

Purpose: Co-delivery of drugs to achieve the synergistic anticancer effect is a promising strategy for lung cancer therapy. The purpose of this research is to develop a doxorubicin (DOX) and β-elemene (ELE) co-loaded, pH-sensitive nanostructured lipid carriers (DOX/ELE Hyd NLCs). Methods: In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Chengsong, Wang, Qun, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498957/
https://www.ncbi.nlm.nih.gov/pubmed/31118562
http://dx.doi.org/10.2147/DDDT.S198003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498957/
https://www.ncbi.nlm.nih.gov/pubmed/31118562
http://dx.doi.org/10.2147/DDDT.S198003

Ejemplares similares